Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
ABBOTINDIA

Abbott India Share Price

 

 

Abbott India live price: ₹26840. It opened at ₹27,095 vs previous close ₹26,855; intraday high/low: ₹27,175/₹26,570. The 50 & 200 DMA stand at ₹26,801.32/₹28,000.40.

Abbott India Performance

  • Today's Low
  • ₹26,570
  • Today's High
  • ₹27,175
  • 52 Week Low
  • ₹25,150
  • 52 Week High
  • ₹37,000
  • Open Price₹27,095
  • Previous Close₹26,855
  • Volume7,107
  • 50 DMA₹26,801.32
  • 100 DMA₹27,144.20
  • 200 DMA₹28,000.40

Abbott India Chart

Investment Returns

  • Over 1 Month + 5.52%
  • Over 3 Month + 1.17%
  • Over 6 Month -10.76%
  • Over 1 Year -11.87%

Smart Investing Starts Here Start SIP with Abbott India for Steady Growth!

Invest Now

Abbott India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.7
  • PEG Ratio
  • 3.8
  • Market Cap Cr
  • 57,033
  • P/B Ratio
  • 13
  • Average True Range
  • 625.22
  • EPS
  • 730.36
  • Dividend Yield
  • 1.8
  • MACD Signal
  • 413.37
  • RSI
  • 48.34
  • MFI
  • 64

Latest Stock News Updates

Q4FY26 & FY26 Result Announced for Abbott India Ltd.

Pharmaceuticals company Abbott India announced Q4FY26 & FY26 results Q4FY26 Financial Highlights: Revenue from Operations: Stood at Rs 1,709.51 crore in Q4FY26, registering a YoY increase of 6.54% compared to Rs 1,604.59 crore in Q4FY25, and a QoQ slight decline of 0.84% from Rs 1,724.04 crore in Q3FY26. Total Income: Reported at Rs 1,785.10 crore in Q4FY26, showing a YoY growth of 6.22% from Rs 1,680.61 crore in Q4FY25, and a QoQ decrease of 0.48% from Rs 1,793.80 crore in Q3FY26. Profit Before Tax (PBT): Reached Rs 531.23 crore in Q4FY26, reflecting a YoY growth of 10.05% against Rs 482.71 crore in Q4FY25, and a QoQ increase of 4.37% compared to Rs 508.98 crore in Q3FY26. Profit for the Period (PAT): Achieved Rs 394.93 crore in Q4FY26, up by 7.60% YoY from Rs 367.04 crore in Q4FY25, and growing 5.05% QoQ from Rs 375.96 crore in Q3FY26. Total Comprehensive Income: Stood at Rs 396.66 crore in Q4FY26, up from Rs 361.60 crore in Q4FY25 and Rs 373.31 crore in Q3FY26. Earnings Per Share (EPS): Basic and Diluted EPS for Q4FY26 was Rs 185.85, an increase from Rs 172.72 in Q4FY25 and Rs 176.92 in Q3FY26. FY26 Financial Highlights: Revenue from Operations: Increased to Rs 6,929.05 crore in FY26, marking a YoY growth of 8.11% from Rs 6,409.15 crore in FY25. Total Income: Jumped to Rs 7,217.19 crore in FY26, representing a YoY growth of 7.96% compared to Rs 6,684.73 crore in FY25. Profit Before Tax (PBT): Grew to Rs 2,079.27 crore in FY26, up by 10.19% YoY from Rs 1,886.95 crore in FY25. Profit for the Year (PAT): Reported at Rs 1,552.02 crore in FY26, indicating a YoY increase of 9.73% against Rs 1,414.44 crore in FY25. Total Comprehensive Income: Achieved Rs 1,551.17 crore in FY26, growing from Rs 1,409.02 crore in FY25. Earnings Per Share (EPS): Basic and Diluted EPS for the full year FY26 was Rs 730.36, compared to Rs 665.62 in FY25. Dividend: The Board of Directors recommended a final dividend of Rs 525 and a special dividend of Rs 131 per equity share of Rs 10 each for FY26. Result PDF

Q3FY26 Quarterly Result Announced for Abbott India Ltd.

Pharmaceuticals company Abbott India announced Q3FY26 results Revenue: Rs 1,724.04 crore against Rs 1,614.28 crore during Q3FY25, change 7%. PBT: Rs 508.98 crore against Rs 487.59 crore during Q3FY25, change 4%. PAT: Rs 375.96 crore against Rs 360.78 crore during Q3FY25, change 4%. EPS: Rs 176.92 for Q3FY26. Result PDF

Abbott India shares gain as Q4 profit jumps 28%; earnings details here

The pharmaceutical company's stock rose as much as 3.86 per cent during the day to 31,500 per share

Abbott India Financials

Abbott India Technicals

EMA & SMA

Current Price
₹26,840.00
-15 (-0.06%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹27,145.02
  • 50 Day
  • ₹26,801.32
  • 100 Day
  • ₹27,144.20
  • 200 Day
  • ₹28,000.40

Resistance and Support

27110 Pivot Speed
  • R3 28,805.00
  • R2 28,325.00
  • R1 27,590.00
  • S1 26,375.00
  • S2 25,895.00
  • S3 25,160.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Abbott India Ltd., develops, manufactures, and sells pharmaceutical products across women's health, gastroenterology, cardiology, metabolic disorders, and primary care. A key player in India’s healthcare sector, Abbott operates with a focus on quality and innovation.

Abbott India has an operating revenue of Rs. 6,929.05 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 30% is great, ROE of 32% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 71 which is a FAIR score but needs to improve its earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 63 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Abbott India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-11 Audited Results & Final Dividend
2026-02-12 Quarterly Results
2025-11-06 Quarterly Results
2025-08-12 Quarterly Results
2025-05-15 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-25 FINAL Rs.475.00 per share(4750%)Final Dividend
2024-07-19 FINAL Rs.410.00 per share(4100%)Final Dividend
2023-07-21 FINAL Rs.180.00 per share(1800%)Final Dividend
2023-07-21 SPECIAL Rs.145.00 per share(1450%)Special Dividend
View Abbott India Dividend History Arrow

Abbott India Shareholding Pattern

74.99%
7.68%
1.04%
0.27%
0.02%
13.38%
2.62%

Abbott India FAQs

Abbott India share price is ₹26,840 As on 01 June, 2026 | 15:49

The Market Cap of Abbott India is ₹57033.1 Cr As on 01 June, 2026 | 15:49

The P/E ratio of Abbott India is 36.7 As on 01 June, 2026 | 15:49

The PB ratio of Abbott India is 13 As on 01 June, 2026 | 15:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23